Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes

Tissue Antigens

Volumn 56, Issue 5, 2000, Pages 436-440

  Verbruggen, L A ^a   Dumarey, N ^a   Van De Velde, H ^b   Rebmann, V ^c   Flament, J ^b   Van Wayenberge, C ^a   Grosse Wilde, H ^c   Demanet, C ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b Rode Kruis Vlaanderen   (Belgium)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

HLA DRB1; Major histocompatibility complex; Rheumatoid arthritis; Soluble HLA DR

Indexed keywords

C REACTIVE PROTEIN; EPITOPE; GENE PRODUCT; HLA DR ANTIGEN; MEMBRANE PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; EDEMA; ERYTHROCYTE SEDIMENTATION RATE; HLA TYPING; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANIMALS; ARTHRITIS, RHEUMATOID; EPITOPES, B-LYMPHOCYTE; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MICE; MIDDLE AGED; RATS; SOLUBILITY;

EID: 0033674577     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.560506.x     Document Type: Article

References (20)

1. Quantitation of soluble HLA class molecules by an enzyme-linked immunosorbent assay
2. Soluble HLA: A review of the literature
3. Immunologically active proteins in intravenous immunoglobulin
4. Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions
5. A preliminary study of serum class II levels in healthy individuals and bone-marrow transplant patients
6. Soluble HLA-I in rheumatic diseases
7. Soluble HLA in human body fluids
8. Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity
9. Soluble HLA class I antigens in patients with systemic lupus erythematosus
10. Soluble HLA class I and class II antigens in patients with multiple sclerosis
11. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
12. The effect of HLA-DRB1 disease susceptibility markers on the expression of RA
13. Association of (Q)R/KRAA-positive HLA-DRB1 alleles with disease progression in early active and severe rheumatoid arthritis
14. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
15. Report on the EULAR standing committee on international clinical studies including therapeutic trials
16. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization
17. Soluble HLA class I and II class concentrations in commercial immunoglobulin preparations
18. Soluble, CD4, CD8, and HLA molecules in commercial immunoglobulin preparations
19. Soluble class I HLA antigens in patients with rheumatoid arthritis and their families
20. Can HLA-DRB1 typing have prognostic value in patients with undifferentiated chronic arthritis?